Erratum: Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial (Cancer (2006) 107, 3 (472-480))

A. U. Buzdar; J. P. Guastalla; J. M. Nabholtz

doi:10.1002/cncr.22259

Erratum: Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial (Cancer (2006) 107, 3 (472-480))

A. U. Buzdar, J. P. Guastalla, J. M. Nabholtz

Breast Medical Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2314
Number of pages	1
Journal	Cancer
Volume	107
Issue number	9
DOIs	https://doi.org/10.1002/cncr.22259
State	Published - Nov 1 2006

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.22259

Cite this

@article{c4ed928a40b941a8b8b25da3d4b185b3,

title = "Erratum: Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial (Cancer (2006) 107, 3 (472-480))",

author = "Buzdar, {A. U.} and Guastalla, {J. P.} and Nabholtz, {J. M.}",

year = "2006",

month = nov,

day = "1",

doi = "10.1002/cncr.22259",

language = "English (US)",

volume = "107",

pages = "2314",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "9",

}

TY - JOUR

T1 - Erratum

T2 - Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial (Cancer (2006) 107, 3 (472-480))

AU - Buzdar, A. U.

AU - Guastalla, J. P.

AU - Nabholtz, J. M.

PY - 2006/11/1

Y1 - 2006/11/1

UR - http://www.scopus.com/inward/record.url?scp=33750504431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750504431&partnerID=8YFLogxK

U2 - 10.1002/cncr.22259

DO - 10.1002/cncr.22259

M3 - Comment/debate

AN - SCOPUS:33750504431

SN - 0008-543X

VL - 107

SP - 2314

JO - Cancer

JF - Cancer

IS - 9

ER -

Erratum: Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial (Cancer (2006) 107, 3 (472-480))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this